List of Excipients in API neomycin sulfate, polymyxin b sulfate and dexamethasone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing neomycin sulfate, polymyxin b sulfate and dexamethasone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | LANOLIN | |
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | METHYLPARABEN | |
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | PETROLATUM | |
| Alcon Laboratories Inc | MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | 0065-0631 | PROPYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing neomycin sulfate, polymyxin b sulfate and dexamethasone
Detailed excipient profiles for neomycin sulfate, polymyxin b sulfate and dexamethasone
Excipient focus: BENZALKONIUM CHLORIDE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing BENZALKONIUM CHLORIDE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: HYDROCHLORIC ACID
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing HYDROCHLORIC ACID
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing HYPROMELLOSE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing HYPROMELLOSE 2910
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing HYPROMELLOSES
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing HYPROMELLOSES
Excipient focus: LANOLIN
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing LANOLIN
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing LANOLIN
Excipient focus: METHYLPARABEN
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing METHYLPARABEN
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing METHYLPARABEN
Excipient focus: PETROLATUM
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing PETROLATUM
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing PETROLATUM
Excipient focus: POLYSORBATE 20
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing POLYSORBATE 20
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing POLYSORBATE 20
Excipient focus: PROPYLPARABEN
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing PROPYLPARABEN
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing SODIUM CHLORIDE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing SODIUM HYDROXIDE
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing SODIUM HYDROXIDE
Excipient focus: WATER
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants containing WATER
neomycin sulfate, polymyxin b sulfate and dexamethasone drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
